The catalyst was anEarningsreport with higher profit guidance. The gap between adjusted EPS of USD 0.34 and GAAP EPS of USD 0.07 matters, because adjusted figures exclude items such asAcquisitionrelated costs and amortization, so investors should read both. When guidance rises while margins expand …
No single catalyst is confirmed here: the third quarter figures were not retrieved, so none are quoted. As general context, aFranchiseinsurance distributor such as Goosehead earns commissions and renewals tied to written premium, so a result that shows steady policy growth, firmer margins or …
The identified catalyst is theEarningsrelease, not aTakeoverorindexevent. Factory-built housing gross margin was 21.1%, down from 22.9%, and consolidated margin slipped 1.7 points to 22.5% from 24.2%, yet revenue growth of 17.9% and a largerBacklogoutweighed that for buyers. Financial services margin rose to 60.2% from …
The catalyst is anEarningsbeat paired with a guidance raise. Full year contribution ex-TAC growth is now about 17% from 13% to 14%, adjusted EBITDA growth about 30% from above 20%, margin about 38.5% from at least 37%, and freeCash Flowgrowth above 60%. Fourth quarter …
Key HighlightsA published screener snapshot of November 5, 2026 showed Sunrun (NASDAQ:RUN) at USD 9.08, up 3.30% on the latest session, 22.87% over one week and 18.69% over one month, placing it among the strongerMid capnames of the week.Longer windows are weaker: the stock …
Key HighlightsA published screener snapshot of November 5, 2026 showed Vertex (NASDAQ:VERX) at USD 17.79, up 11.75% on the latest session, 22.10% over one week and 43.93% over one month, a topMid capperformer.Longer windows are also strong: 50.89% over three months, 20.77% over six …
Key HighlightsA published screener snapshot of November 5, 2026 showed Progyny (NASDAQ:PGNY) at USD 34.20, up 13.62% on the latest session, 22.01% over one week and 32.25% over one month, a topMid capperformer.Longer windows are also strong: 33.80% over three months and 46.22% over …
The catalyst here is anEarningsbeat on product sales paired with a guidance raise. Full year 2026 total revenue is now guided to USD 395 million to USD 405 million, and the nine month total of USD 282.5 million, up 37%, shows the run rate …
No single positive catalyst is clear, because the company cut its 2026 adjusted EBITDA outlook, excluding deferrals and recognitions, to USD 1.165 billion to USD 1.180 billion. General context: when expectations have already been lowered, a reported profit that beats a depressed bar, plus …
The rationale is a guidance raise from a stock priced for low expectations. Full year revenue is now USD 3.44 billion to USD 3.46 billion, from USD 3.40 billion to USD 3.45 billion. Adjusted EBITDA guidance rose to USD 615 million to USD 625 …